Patent application number | Description | Published |
20110027266 | Humanized anti-CXCR5 antibodies, derivatives thereof and their use - The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders. | 02-03-2011 |
20110112101 | TREATMENT FOR OCULAR-RELATED DISORDERS - A treatment for ocular related disorders, such as macular degeneration, and preferably age-related macular degeneration, diabetic retinopathy, and diabetic macular edema is disclosed, using a compound of Formula I. | 05-12-2011 |
20130236476 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use - The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders. | 09-12-2013 |
20130243783 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use - The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders. | 09-19-2013 |
20130243793 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use - The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders. | 09-19-2013 |
20130246035 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use - The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders. | 09-19-2013 |
20130251714 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use - The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders. | 09-26-2013 |